ASTHAstrana Health, Inc.
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Price is +19% vs its 200-day average.
Moderately shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ASTH is trading
Astrana Health, Inc. is +35% over the past year while the S&P 500 is +18%: 17 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +19%
vs 200-day average · a clear uptrend
- RSI (14)
- 67
RSI (14) · neutral
- Below its 52-week high
- 23%
Below its 52-week high
Details›
- Last close2026-10-09
- $37.58
- 1 monthS&P 500 +2.7%
- −1.2%
- 1 yearS&P 500 +18%
- +35%
- 5 yearsS&P 500 +88%
- −59%
- vs 50-day average$37.03
- +1.5%
- 52-week high
- $49.01
- 52-week low
- $18.16
- Annualised volatility
- 66%
| Year | Return |
|---|---|
| 2026 (year to date) | +51% |
| 2025 | −21% |
| 2024 | −18% |
| 2023 | +29% |
| 2022 | −60% |
| 2021 | +302% |
| 2020 | −0.76% |
| 2019 | −7.3% |
| 2018 | −17% |
| 2017 | +220% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | +1.9% |
| Feb | 10 | 4 of 10 | −1.4% |
| Mar | 10 | 5 of 10 | −0.14% |
| Apr | 10 | 7 of 10 | +5.0% |
| May | 10 | 6 of 10 | +1.9% |
| Jun | 10 | 5 of 10 | +16% |
| Jul | 11 | 5 of 11 | +7.6% |
| Aug | 11 | 5 of 11 | −1.3% |
| Sep | 11 | 4 of 11 | +3.4% |
| Oct | 11 | 3 of 11 | −6.7% |
| Nov | 10 | 5 of 10 | −5.1% |
| Dec | 10 | 8 of 10 | +54% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.